The two blockbusters have made a big difference in bladder cancer survival, but will their chemistry hold up when tested in other types?

The patient came in with a belly full of blood, Dr. Leilah Zahedi-Spung recalled. Her pregnancy was ectopic, no longer viable, and could have killed her if left untreated. But ...

Extensive toxicological and epidemiological research has shown that these carcinogens cause DNA damage, mutational signatures ...

Neoadjuvant sacituzumab govitecan plus pembrolizumab achieved a 39% clinical complete response requiring concordant radiographic negativity and pathologic clearance ...

Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...

Not everyone is cut out to be in the medical field, and these stories explain why.

It's OK, I'll turn my back while you add these products to your cart. View Entire Post › ...

For years, Susan Johnstone, 53, lived with an embarrassing problem that threatened to take away the activity she loved most: ...

WVU Medicine Reynolds Memorial Hospital recently completed its first implant of the Altaviva device, developed by Medtronic, a new treatment option to ...

Dr. Pooja Ghatalia presents findings from RETAIN-2, a single-arm phase 2 non-randomized trial evaluating a ...